ACC 2019: The DEFINE PCI Trial: Blinded Physiologic Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention

Up Next

Interview

ACC 2019: ADVANCE Registry: Impact of FFRCT on 1-Year Outcomes in Patients Evaluated: Lessons from the ADVANCE Registry

March 18, 2019

More Videos +

Interview

ACC 2019: PANACHE: Safety and Efficacy of Neladenoson Bialanate, a Partial Adenosine A1 Receptor Agonist, in Patients with Heart Failure and Preserved Ejection Fraction: Results from the PANACHE Randomized Controlled Trial

March 18, 2019

Conference Wrap-Up

ACC 2019: Wrap Up from the perspective of the Netherlands

March 18, 2019